MEDLOCK; Eugene

Patent Applications and Registrations

Patent applications and USPTO patent grants for MEDLOCK; Eugene.The latest application filed is for "methods of treatment using il-17e antagonists".

Company Profile

0.8.20

MEDLOCK; Eugene - Westlake Village CA
Medlock; Eugene - Westlake CA
Medlock; Eugene - West Lake Village CA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Methods Of Treatment Using Il-17e Antagonists App 20140037635 - MEDLOCK; Eugene ; et al.	2014-02-06
Human Anti-OPGL Neutralizing Antibodies as Selective OPGL Pathway Inhibitors App 20130171168 - Boyle; William J. ; et al.	2013-07-04
Human Anti-OPGL Neutralizing Antibodies As Selective OPGL Pathway Inhibitors App 20130164292 - Boyle; William J. ; et al.	2013-06-27
Human anti-OPGL neutralizing antibodies as selective OPGL pathway inhibitors Grant 8,455,629 - Boyle , et al. June 4, 2	2013-06-04
Human anti-OPGL neutralizing antibodies as selective OPGL pathway inhibitors Grant 8,367,063 - Boyle , et al. February 5, 2	2013-02-05
Human Anti-OPGL Neutralizing Antibodies As Selective OPGL Pathway Inhibitors App 20120156725 - Boyle; William J. ; et al.	2012-06-21
Il-17 Receptor Like Molecules And Uses Thereof App 20110160438 - Medlock; Eugene ; et al.	2011-06-30
IL-17 receptor like molecules and uses thereof Grant 7,943,738 - Medlock , et al. May 17, 2	2011-05-17
Human Anti-OPGL Neutralizing Antibodies as Selective OPGL Pathway Inhibitors App 20110052604 - Boyle; William J. ; et al.	2011-03-03
Methods Of Treatment Using Il-17e Antagonists App 20100303820 - Medlock; Eugene ; et al.	2010-12-02
Human Anti-OPGL Neutralizing Antibodies As Selective OPGL Pathway Inhibitors App 20100209435 - Boyle; William J. ; et al.	2010-08-19
Human anti-OPGL neutralizing antibodies as selective OPGL pathway inhibitors Grant 7,718,776 - Boyle , et al. May 18, 2	2010-05-18
IL-17 receptor like molecules and uses thereof App 20090281287 - Medlock; Eugene ; et al.	2009-11-12
IL-receptor like molecules and uses thereof Grant 7,611,857 - Medlock , et al. November 3, 2	2009-11-03
IL-17 like molecules and uses thereof App 20070123459 - Medlock; Eugene ; et al.	2007-05-31
IL-17 receptor like molecules and uses thereof Grant 7,094,566 - Medlock , et al. August 22, 2	2006-08-22
Antibodies for IL-17 receptor like polypeptides and uses thereof App 20060078967 - Medlock; Eugene ; et al.	2006-04-13
IL-receptor like molecules and uses thereof App 20060078933 - Medlock; Eugene ; et al.	2006-04-13
IL-17 receptor like polypeptides and uses thereof App 20060078966 - Medlock; Eugene ; et al.	2006-04-13
Il-17 Receptor Like Molecules And Uses Thereof App 20050234221 - Medlock, Eugene ; et al.	2005-10-20
IL-17 like molecules and uses thereof App 20050074427 - Medlock, Eugene ; et al.	2005-04-07
Il-17 like molecules and uses thereof App 20050048029 - Medlock, Eugene ; et al.	2005-03-03
IL-17 like molecules and uses thereof App 20050003451 - Medlock, Eugene ; et al.	2005-01-06
Human anti-OPGL neutralizing antibodies as selective OPGL pathway inhibitors App 20040023313 - Boyle, William J. ; et al.	2004-02-05
IL-17 like molecules and uses thereoflike molecules and uses thereof App 20030124092 - Medlock, Eugene ; et al.	2003-07-03
IL-17 like molecules and uses thereof App 20020037524 - Medlock, Eugene ; et al.	2002-03-28

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.